Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332.SS)
CNY 28.85
(0.17%)
CNY 28.85
(0.17%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 4.48 Billion | 6.99 Billion | 5.67 Billion | 585.18 Million | 5.02 Billion | 5.21 Billion |
| Net Income | 4.05 Billion | 4.25 Billion | 3.96 Billion | 3.09 Billion | 3.44 Billion | 3.53 Billion |
| Depreciation & Amortization | 985.32 Million | 743.82 Million | 676.99 Million | 644.19 Million | 591.89 Million | 301.22 Million |
| Deferred income taxes | -53.26 Million | -8.24 Million | 2.85 Million | -137.27 Million | -8.7 Million | -115.42 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1.31 Billion | 1.87 Billion | 860.49 Million | -3.32 Billion | 692.41 Million | 2.27 Billion |
| Other non-cash items | 4.1 Billion | 123.29 Million | 167.02 Million | 175.49 Million | 296.76 Million | -896.34 Million |
| Investing Cash Flow | -3.47 Billion | -7.25 Billion | -931.56 Million | -1.08 Billion | -1.02 Billion | 1.1 Billion |
| Investments in PPE | -1.62 Billion | -1.38 Billion | -1.25 Billion | -876.5 Million | -2.39 Billion | -478.61 Million |
| Acquisitions | 33.89 Million | -1.9 Million | 31.17 Million | 6.14 Million | -2.22 Million | - |
| Investment purchases | -4.3 Billion | -6.91 Billion | -402.16 Million | -610.77 Million | -353.87 Million | -3.17 Billion |
| Sales/Maturities of investments | 2.42 Billion | 899.46 Million | 687.5 Million | 427.72 Million | 1.72 Billion | 3.81 Billion |
| Other Investing Activities | 34.26 Thousand | 151.1 Million | 6.83 Million | -34.64 Million | 1.16 Million | 945.37 Million |
| Financing Cash Flow | -1.99 Billion | 45.94 Million | -1.49 Billion | 1.43 Billion | -2.23 Billion | -2.75 Billion |
| Debt repayment | -373.75 Million | -8.15 Billion | -8.65 Billion | -6.15 Billion | -832.74 Million | -3.57 Billion |
| Dividends payments | -1.19 Billion | -1.11 Billion | -874.67 Million | -957.59 Million | -689.33 Million | -870.55 Million |
| Common Stock Repurchased | - | - | - | - | - | 1.36 Billion |
| Common Stock Issuance | - | - | - | - | - | 257.98 Million |
| Other Financing Activities | -434.12 Million | 9.68 Billion | 8.42 Billion | 8.88 Billion | -353.38 Million | 71.11 Million |
| Accounts receivables | -417.27 Million | -1.99 Billion | -1.62 Billion | -572.16 Million | -1.86 Billion | 27.96 Million |
| Accounts payables | -66.12 Million | 4.12 Billion | 3.15 Billion | -2.35 Billion | 2.79 Billion | 4.36 Billion |
| Inventory | -835.02 Million | -242.22 Million | -673.65 Million | -265.44 Million | -221.36 Million | -2 Billion |
| Other working capital | -1.00 | -8.24 Million | 2.85 Million | -137.27 Million | -8.7 Million | 4.28 Billion |
| Cash at beginning of period | 22.44 Billion | 21.01 Billion | 17.76 Billion | 16.83 Billion | 15.07 Billion | 11.49 Billion |
| Cash at end of period | 21.27 Billion | 20.8 Billion | 21.01 Billion | 17.76 Billion | 16.83 Billion | 15.07 Billion |
| Capital Expenditure | -1.62 Billion | -1.38 Billion | -1.25 Billion | -876.5 Million | -2.39 Billion | -478.61 Million |
| Effect of forex changes on cash | 8.07 Million | -503.25 Thousand | 282.82 Thousand | -4.99 Million | -148.47 Thousand | 807 Thousand |
| Net cash flow / Change in cash | -1.16 Billion | -208.66 Million | 3.24 Billion | 931.51 Million | 1.76 Billion | 3.57 Billion |
| Free Cash Flow | 2.85 Billion | 5.61 Billion | 4.41 Billion | -291.31 Million | 2.62 Billion | 4.73 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 609.41 Million | 591.44 Million | 1.95 Billion | 264.42 Million | 4.05 Billion | 980 Million |
| Depreciation & Amortization | - | 240.8 Million | 240.8 Million | 223.25 Million | 985.32 Million | -486.58 Million |
| Deferred income taxes | - | - | - | - | -53.26 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -1.5 Billion | - | -1.25 Billion | -1.31 Billion | -186.69 Million |
| Other non-cash items | 719.67 Million | 781.67 Million | -5.06 Billion | 4.01 Billion | 4.1 Billion | 1.33 Billion |
| Investing Cash Flow | -325.12 Million | -3.63 Billion | -282.99 Million | -956.65 Million | -3.47 Billion | -1.25 Billion |
| Investments in PPE | -247.3 Million | -245.89 Million | -318.77 Million | -471.26 Million | -1.62 Billion | -397.89 Million |
| Acquisitions | 38.1 Million | -12.73 Million | 5.29 Million | 7.51 Million | 33.89 Million | 1.32 Million |
| Investment purchases | -596.84 Million | -3.48 Billion | -40 Million | -895 Million | -4.3 Billion | -1.7 Billion |
| Sales/Maturities of investments | 518.71 Million | 102.86 Million | 75.69 Million | 400.77 Million | 2.42 Billion | 843.89 Million |
| Other Investing Activities | 307.92 Thousand | -3.38 Billion | 35.77 Million | 1.31 Million | 34.26 Thousand | -1.31 Million |
| Financing Cash Flow | -7.77 Million | -1.34 Billion | 1.93 Billion | -1.06 Billion | -1.99 Billion | -1.59 Billion |
| Debt repayment | -348.4 Million | -32.64 Million | -2 Billion | -522.65 Million | -373.75 Million | -2.26 Billion |
| Dividends payments | -261.99 Million | -1.14 Billion | -76.99 Million | -1.19 Billion | -1.19 Billion | -264.29 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -94.17 Million | -154.55 Million | 19.35 Million | 651.5 Million | -434.12 Million | 941.8 Million |
| Accounts receivables | - | -2.25 Billion | - | -417.27 Million | -417.27 Million | 1.32 Billion |
| Accounts payables | - | - | - | - | -66.12 Million | - |
| Inventory | - | 754.94 Million | - | -835.02 Million | -835.02 Million | -1.51 Billion |
| Other working capital | - | - | - | - | -1.00 | - |
| Cash at beginning of period | 14.47 Billion | 18.34 Billion | 19.82 Billion | 19.87 Billion | 22.44 Billion | 19.78 Billion |
| Cash at end of period | 15.42 Billion | 14.47 Billion | 18.34 Billion | 21.27 Billion | 21.27 Billion | 18.58 Billion |
| Capital Expenditure | -247.3 Million | -245.89 Million | -318.77 Million | -471.26 Million | -1.62 Billion | -397.89 Million |
| Effect of forex changes on cash | 729.37 Thousand | 1.84 Million | 2.43 Million | 1.32 Million | 8.07 Million | 2.98 Million |
| Net cash flow / Change in cash | 953.2 Million | -3.87 Billion | -1.47 Billion | 1.4 Billion | -1.16 Billion | -1.2 Billion |
| Free Cash Flow | 1.08 Billion | 886.41 Million | -3.42 Billion | 2.78 Billion | 2.85 Billion | 1.24 Billion |
0573
OVT
5243
SZGPF
058730
002153